新生児スクリーニングの市場規模、シェア、動向分析レポート：技術別、検査タイプ別、製品別、地域別、セグメント別予測、2023年～2030年

新生児スクリーニング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の新生児スクリーニング市場規模は2030年までに14億米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 7.54％で拡大すると予測されます。新生児スクリーニング市場の成長は、有利な償還政策や政府支援プログラム、効率的なスクリーニング検査の開発に注力する主要企業の存在が主な要因です。加えて、中国やインドといった最も人口の多い経済圏における高い出生率と高い可処分所得は、市場を積極的に牽引すると予想される要因です。

Indian Paediatrics Report 2022によると、NBSは公衆衛生予防の定番となっており、そのパネルは常に増加しています。特定のDBSベースの代謝検査ツールは、NBSにおいて引き続き重要です。遺伝学的検査とゲノム検査は、科学の進歩により効果的なツールとなっています。しかし、どちらにも利点と欠点があります。一部の遺伝性疾患に対する現在のNBSの効率は、代謝データと遺伝子データの統合分析によって向上し、より多くの罹患者が早期診断と治療を受けられるようになり、予後が改善されます。

さらに、政府のプログラムや法律も、市場成長を促進する有利な環境を作り出しています。新生児スクリーニングプログラムは、世界の子供たちの健康を守るためにWHOによって推奨されました。このプログラムの下で、日本の産科婦人科学会（JSOG）、米国保健社会福祉省新生児と小児の遺伝性疾患に関する長官諮問委員会（SACHDNC）、英国（PEACH）、March of Dimesのような擁護団体によって、数多くの政策やイニシアチブが取られてきました。

さらに2022年6月、ノバルティスは米国血液学会と戦略的パートナーシップを締結し、さらにアフリカ6カ国の新生児の鎌状赤血球症に取り組んでいます。ASHのConsortium on Newborn Screening in Africa（CONSA）は、ガーナ、リベリア、ケニア、ナイジェリア、タンザニア、ウガンダ、ザンビアなどの国々の複数の施設で早期介入とスクリーニングプログラムを提供します。

さらに、新生児スクリーニングの分野における技術革新への注目が高まることで、市場の成長が促進されると予想されます。例えば、2022年8月、Trivitron Healthcareは、新生児スクリーニング、ゲノミクス、分子診断、メタボロミクスのためのCentre of Excellenceを立ち上げました。新生児スクリーニング用のELISA、PCR、IVD CE承認キットに基づくがんマーカーはこの施設で製造されます。

新生児スクリーニング市場レポートハイライト

• 検査タイプ別では、2022年の新生児スクリーニング市場全体では乾燥血液スポット検査分野が優位を占めました。50以上の疾患の診断のために、出生後24～48時間以内にスクリーニングカードで新生児の踵から血液を採取することを、踵刺または乾燥血液スポット（DBS）検査と呼びます。
• 技術別では、タンデム質量分析が、その費用対効果、高い適用性、技術的アップグレードによる高い需要により、2022年の市場全体を支配しました。
• アジア太平洋地域は、2022年の新生児スクリーニング市場で最大のシェアを占めました。インフラとヘルスケア計画の改善、拡大のための新たな機会の利用可能性は、予測期間にわたって地域市場の需要を促進する上で大きな役割を果たすと予想されます。
• 業界各社は、持続可能性を確保するため、戦略的パートナーシップやM&Aに積極的に取り組んでいます。例えば、Trivitron HealthcareとAgilent Technologiesは、LC-MS/MSプラットフォームに基づく高精度の体外診断分野で提携を開始しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19感染症の影響分析

第4章 新生児スクリーニング市場：技術分析

• 新生児スクリーニング市場：技術の変動分析
• タンデム質量分析
• パルスオキシメーター
• 酵素ベースのアッセイ
• DNAアッセイ
• 電気泳動
• その他

第5章 新生児スクリーニング市場：検査タイプ分析

• 新生児スクリーニング市場：検査タイプの変動分析
• 乾燥血液スポット（DBS）検査
• CCHD
• 聴覚スクリーニング

第6章 新生児スクリーニング市場：製品分析

• 新生児スクリーニング市場：製品の変動分析
• 機器
• 試薬

第7章 新生児スクリーニング市場：地域分析

• 地域別の新生児スクリーニング市場シェア、2022年および2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業の分類
• 戦略マッピング
• 企業の市場シェア分析、2022年
• 企業プロファイル・一覧表
  • Covidien Plc.
  • AB SCIEX
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Masimo Corporation
  • Waters Corporation
  • Natus Medical
  • Trivitron Healthcare
  • GE Lifesciences
  • PerkinElmer Inc

List of Tables

• Table 1 List of abbreviations
• Table 2 Global newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 3 Global newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 4 Global newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 5 Global newborn screening market, by region, 2018 - 2030 (USD Million)
• Table 6 North America newborn screening market, by country, 2018 - 2030 (USD Million)
• Table 7 North America newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 8 North America newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 9 North America newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 10 U.S. newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 11 U.S. newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 12 U.S. newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 13 Canada newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 14 Canada newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 15 Canada newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 16 Europe newborn screening market, by country, 2018 - 2030 (USD Million)
• Table 17 Europe newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 18 Europe newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 19 Europe newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 20 UK newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 21 UK newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 22 UK newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 23 Germany newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 24 Germany newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 25 Germany newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 26 France newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 27 France newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 28 France newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 29 Italy newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 30 Italy newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 31 Italy newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 32 Spain newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 33 Spain newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 34 Spain newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 35 Denmark newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 36 Denmark newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 37 Denmark newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 38 Sweden newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 39 Sweden newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 40 Sweden newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 41 Norway newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 42 Norway newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 43 Norway newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific newborn screening market, by country, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 48 Japan newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 49 Japan newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 50 Japan newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 51 China newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 52 China newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 53 China newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 54 India newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 55 India newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 56 India newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 57 Australia newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 58 Australia newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 59 Australia newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 60 Thailand newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 61 Thailand newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 62 Thailand newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 63 South Korea newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 64 South Korea newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 65 South Korea newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 66 Latin America newborn screening market, by country, 2018 - 2030 (USD Million)
• Table 67 Latin America newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 68 Latin America newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 69 Latin America newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 70 Brazil newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 71 Brazil newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 72 Brazil newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 73 Mexico newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 74 Mexico newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 75 Mexico newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 76 Argentina newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 77 Argentina newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 78 Argentina newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa newborn screening market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 83 South Africa newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 84 South Africa newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 85 South Africa newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 89 UAE newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 90 UAE newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 91 UAE newborn screening market, by test type, 2018 - 2030 (USD Million)
• Table 92 Kuwait newborn screening market, by product, 2018 - 2030 (USD Million)
• Table 93 Kuwait newborn screening market, by technology, 2018 - 2030 (USD Million)
• Table 94 Kuwait newborn screening market, by test type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Newborn Screening market segmentation
• Fig. 8 Market snapshot, 2022
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 PESTEL analysis
• Fig. 13 Porter's five forces analysis
• Fig. 14 Global newborn screening market: Product movement analysis
• Fig. 15 Global newborn screening market, for instruments, 2018 - 2030 (USD Million)
• Fig. 16 Global newborn screening market, for reagents, 2018 - 2030 (USD Million)
• Fig. 17 Global newborn screening market: Technology movement analysis
• Fig. 18 Global newborn screening market, for tandem mass spectrometry, 2018 - 2030 (USD Million)
• Fig. 19 Global newborn screening market, for pulse oximetry, 2018 - 2030 (USD Million)
• Fig. 20 Global newborn screening market, for enzyme based assay technology, 2018 - 2030 (USD Million)
• Fig. 21 Global newborn screening market, for DNA assays technology, 2018 - 2030 (USD Million)
• Fig. 22 Global newborn screening market, for electrophoresis technology, 2018 - 2030 (USD Million)
• Fig. 23 Global newborn screening market, for other technologies, 2018 - 2030 (USD Million)
• Fig. 24 Global newborn screening market: Test type movement analysis
• Fig. 25 Global newborn screening market, for Dry blood spot test, 2018 - 2030 (USD Million)
• Fig. 26 Global newborn screening market, for CCHD, 2018 - 2030 (USD Million)
• Fig. 27 Global newborn screening market, for Hearing Screen, 2018 - 2030 (USD Million)
• Fig. 28 Regional marketplace: Key takeaways
• Fig. 29 Regional outlook, 2022 & 2030
• Fig. 30 Global newborn screening market: Regional movement analysis
• Fig. 31 North America newborn screening market, 2018 - 2030 (USD Million)
• Fig. 32 U.S. newborn screening market, 2018 - 2030 (USD Million)
• Fig. 33 Canada newborn screening market, 2018 - 2030 (USD Million)
• Fig. 34 Europe newborn screening market, 2018 - 2030 (USD Million)
• Fig. 35 Germany newborn screening market, 2018 - 2030 (USD Million)
• Fig. 36 UK newborn screening market, 2018 - 2030 (USD Million)
• Fig. 37 France newborn screening market, 2018 - 2030 (USD Million)
• Fig. 38 Italy newborn screening market, 2018 - 2030 (USD Million)
• Fig. 39 Spain newborn screening market, 2018 - 2030 (USD Million)
• Fig. 40 Denmark newborn screening market, 2018 - 2030 (USD Million)
• Fig. 41 Sweden newborn screening market, 2018 - 2030 (USD Million)
• Fig. 42 Norway newborn screening market, 2018 - 2030 (USD Million)
• Fig. 43 Asia Pacific newborn screening market, 2018 - 2030 (USD Million)
• Fig. 44 Japan newborn screening market, 2018 - 2030 (USD Million)
• Fig. 45 China newborn screening market, 2018 - 2030 (USD Million)
• Fig. 46 India newborn screening market, 2018 - 2030 (USD Million)
• Fig. 47 Australia newborn screening market, 2018 - 2030 (USD Million)
• Fig. 48 South Korea newborn screening market, 2018 - 2030 (USD Million)
• Fig. 49 Thailand newborn screening market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America newborn screening market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil newborn screening market, 2018 - 2030 (USD Million)
• Fig. 52 Mexico newborn screening market, 2018 - 2030 (USD Million)
• Fig. 53 Argentina newborn screening market, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa newborn screening market, 2018 - 2030 (USD Million)
• Fig. 55 South Africa newborn screening market, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia newborn screening market, 2018 - 2030 (USD Million)
• Fig. 57 UAE newborn screening market, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait newborn screening market, 2018 - 2030 (USD Million)

Newborn Screening Market Growth & Trends:

The global newborn screening market size is expected to reach USD 1.40 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.54% from 2023 to 2030. The growth of the market for newborn screening is majorly attributed to favorable reimbursement policies and government support programs, as well as the presence of key players focusing on developing efficient screening tests. In addition, high birth rates in the most populous economies such as China and India, coupled with high disposable income, are factors anticipated to drive the market positively.

According to Indian Paediatrics Report 2022, NBS has become a staple in public health prevention, and its panel is always growing. Specific DBS-based metabolic testing tools continue to be crucial in NBS. Genetic and genomic testing have become effective tools because of scientific advancements. Both, however, have advantages and drawbacks. The present NBS efficiency for some genetic illnesses will be increased by the integrated analysis of metabolic and genetic data, allowing more affected people to obtain early diagnosis and treatment, which will improve their prognosis.

In addition, government programs and legislation also create a favorable environment to foster market growth. The newborn screening program was recommended by the WHO to safeguard the health of children globally. Under this program, numerous policies and initiatives have been taken by the Japan's Society of Obstetrics and Gynecology (JSOG), U.S. Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC), UK (PEACH), and advocacy groups like the March of Dimes.

Moreover, in June 2022, Novartis entered into a strategic partnership with the American Society of Hematology to deal with sickle cell disease amongst newborns in an additional six African countries. ASH's Consortium on Newborn Screening in Africa (CONSA) will provide early intervention and screening programs at several institutions in countries such as Ghana, Liberia, Kenya, Nigeria, Tanzania, Uganda, and Zambia.

Additionally, more focus on innovation in the field of newborn screening is expected to drive market growth. For instance, in August 2022, Trivitron Healthcare launched a Centre of Excellence for newborn screening, genomics, molecular diagnostics, and metabolomics. Cancer markers based on ELISA, PCR, and IVD CE-approved kits for newborn screening will be manufactured at the facility.

Newborn Screening Market Report Highlights:

• By test type, the dry blood spot test segment dominated the overall market for newborn screening in 2022. The collection of blood from a newborn's heel within 24-48 hours of birth on the screening card for diagnosis of over 50 conditions is termed a heel stick or dried blood spot (DBS) test
• By technology, tandem mass spectrometry dominated the overall market in 2022 owing to high demand due to its cost-effectiveness, higher applicability, and technological upgrades
• Asia Pacific accounted for the largest share of the market for newborn screening in 2022. Improving infrastructure and healthcare plans and the availability of new opportunities for expansion are expected to play a major role in driving regional market demand over the forecast period
• Industry players are actively involved in strategic partnerships and mergers & acquisitions in order to ensure sustainability. For example, Trivitron Healthcare and Agilent Technologies have partnered to initiate collaboration in the area of high-precision in-vitro diagnostics based on the LC-MS/MS platform

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Test type segment
    • 1.1.1.2. Product segment
    • 1.1.1.3. Technology segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
  • 1.4.3. Objective - 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Test Type and Product Snapshot
• 2.3. Technology Snapshot
• 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Newborn Screening Market: Technology Analysis

• 4.1. Newborn Screening Market: Technology Movement Analysis
• 4.2. Tandem mass spectrometry
  • 4.2.1. Tandem mass spectrometry market, 2018 - 2030 (USD Million)
• 4.3. Pulse oximetry
  • 4.3.1. Pulse oximetry market, 2018 - 2030 (USD Million)
• 4.4. Enzyme based assay
  • 4.4.1. Enzyme based assays market, 2018 - 2030 (USD Million)
• 4.5. DNA assays
  • 4.5.1. DNA assays market, 2018 - 2030 (USD Million)
• 4.6. Electrophoresis
  • 4.6.1. Electrophoresis market, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Other technologies market, 2018 - 2030 (USD Million)

Chapter 5. Newborn Screening Market: Test Type Analysis

• 5.1. Newborn Screening Market: Test Type Movement Analysis
• 5.2. Dry blood spot test
  • 5.2.1. Dry blood spot test market, 2018 - 2030 (USD Million)
• 5.3. CCHD
  • 5.3.1. CCHD test market, 2018 - 2030 (USD Million)
• 5.4. Hearing screen
  • 5.4.1. Hearing screen test market, 2018 - 2030 (USD Million)

Chapter 6. Newborn Screening Market: Product Analysis

• 6.1. Newborn Screening Market: Product Movement Analysis
• 6.2. Instruments
  • 6.2.1. Instruments market, 2018 - 2030 (USD Million)
• 6.3. Reagents
  • 6.3.1. Reagents market, 2018 - 2030 (USD Million)

Chapter 7. Newborn Screening Market: Regional Analysis

• 7.1. Newborn Screening Market Share By Region, 2022 & 2030
• 7.2. North America
  • 7.2.1. North America Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Target Disease Prevalence
    • 7.2.2.3. Competitive Scenario
    • 7.2.2.4. Regulatory Framework
    • 7.2.2.5. U.S. Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Target Disease Prevalence
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Regulatory Framework
    • 7.2.3.5. Canada Newborn Screening Market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. UK Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Germany Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. France Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Target Disease Prevalence
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Regulatory Framework
    • 7.3.5.5. Italy Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Target Disease Prevalence
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Regulatory Framework
    • 7.3.6.5. Spain Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Target Disease Prevalence
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Regulatory Framework
    • 7.3.7.5. Denmark Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Target Disease Prevalence
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Regulatory Framework
    • 7.3.8.5. Sweden Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Target Disease Prevalence
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Regulatory Framework
    • 7.3.9.5. Norway Newborn Screening Market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. Japan Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. China Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. India Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Australia Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Thailand Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. South Korea Newborn Screening Market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Brazil Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. Mexico Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.5.4. Argentina
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
    • 7.5.4.5. Argentina Newborn Screening Market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. South Africa Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Saudi Arabia Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
    • 7.6.4.5. UAE Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Regulatory Framework
    • 7.6.5.5. Kuwait Newborn Screening Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Share Analysis, 2022
• 8.4. Company Profiles/Listing
  • 8.4.1. Covidien Plc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. AB SCIEX
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Bio-Rad Laboratories
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Agilent Technologies
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Masimo Corporation
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Waters Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Natus Medical
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Trivitron Healthcare
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. GE Lifesciences
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. PerkinElmer Inc
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives